GPR65 Antikörper (1st Cytoplasmic Domain)
Kurzübersicht für GPR65 Antikörper (1st Cytoplasmic Domain) (ABIN1735147)
Target
Alle GPR65 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- 1st Cytoplasmic Domain
-
Spezifität
- Reacts with human GPR65
-
Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 16 amino acid peptide from 1st cytoplasmic domain of human GPR65. Percent identity with other species by BLAST analysis: Human (94%), Gorilla (94%), Gibbon (94%), Monkey (94%), Marmoset (94%), Mouse (94%), Rat (94%), Dog (94%), Bat (94%)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: IHC-P (4 μg/mL - 11
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- GPR65 (G Protein-Coupled Receptor 65 (GPR65))
-
Andere Bezeichnung
- GPR65
-
UniProt
- Q8IYL9
-
Pathways
- cAMP Metabolic Process
Target
-